Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Contribution statement RM conducted the analyses, prepared tables and figures, interpreted the data and co-wrote the manuscript
Future research should further validate these findings and explore the specific biological mechanisms through which Cu and Fe influence FM risk
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
Despite that 510% WL is clinically beneficial, greater WL may be required for the individual to improve or achieve remission of some obesity-related complications [7, 8]
LeRoith D, Gavrilova O
US$ 27.18
US$ 27.60
US$ 27.62
US$ 26.77
US$ 27.98
US$ 25.06
US$ 28.20
US$ 24.13
